Abstract
The common goal of pediatric and adult spinal reconstructive procedures is to minimize long-term risk of disability, pain, and mortality. A common complication that has proved particularly problematic in the adult spinal deformity population and that has been an area of increased research and clinical focus is proximal junctional kyphosis (PJK). The incidence of PJK ranges from 10%–40% based on criteria used to define the condition. Clinically, PJK complication is associated with increased pain, decreased self-image and Scoliosis Research Society scores, and severe neurological injuries affecting the patient’s quality of life. Economically, direct costs of PJK complication-associated revision surgery ranges from $20,000 to $120,000, which places an enormous burden on patients, providers, and payers. To mitigate the risk of PJK occurrence postoperatively, it is paramount to develop consistent guidelines in defining and classifying PJK in addition to extensive preoperative planning and risk stratification that is patient specific. This article will provide an overview on the clinical and economic impact of PJK in pediatric and adult spine deformity patients with an emphasis on the role of patient factors and predictive analytics, challenges in developing a consistent PJK classification, and current treatment and prevention strategies.
Footnotes
Funding The authors received no financial support for the research, authorship, and/or publication of this article.
Declaration of Conflicting Interests J.G.: Consultant: Acuity, Depuy, Medtronic, Nuvasive, Stryker, FYR Medical; Royalties: Acuity, Medtronic, Nuvasive; Advisory Board: Medtronic, Stryker; Medical Board: National Spine Health Foundation; Stock: Cingulate Therapeutics, FYR Medical; Patent: Medtronic; Research: Stryker, Cerapedics, Inc., Biom’Up, empirical Spine, Pfizer, Texas Scottish Rite Hospital, Alan L. & Jacqueline B. Stuart Spine Research, Scoliosis Research Society, National Spine Health Foundation; Staff: Norton Health Care, Inc.; Honorarium: Baxter, Broadwater, NASS, Pacira Pharmaceuticals.
- This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery. Copyright © 2023 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.